Featured Story | By Nick Paul Taylor Sanofi has posted early-phase data on its recombinant IL-2 molecule in solid tumor patients. Analysts at Jefferies called the data “intriguing” while noting it is currently hard to tell whether the drug improves on the IL-2 pathway agonist Bristol Myers Squibb is developing in partnership with Nektar Therapeutics. read more |
| |
|---|
|
Top Stories By Ben Adams As a Democrat-led U.S. government is looking to once again up the pressure on drug pricing, a new report has shown biopharmas are in fact reinvesting more and more sales revenue into R&D. read more By Amirah Al Idrus Project Onramp kicked off in 2019 to connect low-income students across Massachussetts to well-paid summer internships at local biotech companies. Since then, the internship program has weathered the COVID-19 pandemic, connected students and companies outside of Massachusetts through virtual internships and expanded into a new city: Philadelphia. read more Sponsored By: BioIVT Non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH) are common pathologies without specialized therapeutics, but new models may provide opportunities for drug discovery. read more By Nick Paul Taylor Provention Bio has warned the approval of teplizumab in Type 1 diabetes is likely to be delayed by a request for more information from the FDA. The advisory committee meeting is still scheduled to go ahead late next month, but the July 2 PDUFA date is now under threat. read more By Ben Adams After banking $72 million at the start of the year, Werewolf Therapeutics now wants an IPO. read more By Andrea Park It goes against all medical knowledge and basic common sense to say that vital signs are only skin deep, but that’s exactly the case for a newly FDA-cleared platform from Israel's Donisi Health that can detect shifts in cardiac and pulmonary performance from afar. read more By Angus Liu Takeda and CSL's COVID-19 plasma-derived therapy failed a phase 3 trial. Daiichi Sankyo expects nearly $6 billion in cancer sales in fiscal 2025. Legend Biotech and Johnson & Johnson finished a rolling submission of their CAR-T therapy cilta-cel in multiple myeloma. And more. read more By Fraiser Kansteiner Bluebird's former CMO has landed at Tessera three weeks after flying the nest. Thermo Fisher veteran Zhang has landed the CEO spot at genomics up-and-comer Mission Bio. Medable, enjoying a pandemic boost to its decentralized trial services, has tapped Pamela Tenaerts, M.D., as its chief scientific officer. read more Resources Sponsored By: August Bioservices How has COVID-19 impacted CRO/CDMO customer (dis)satisfaction and outsourcing decisions for pharma and biotech companies in 2021 and beyond? Sponsored by: Cytiva A one-stop hub for Cytiva resources to support process development and manufacturing of your novel molecule Sponsored by: PerkinElmer Informatics Discover the benefits of a cloud-native ELN that delivers better performance, security, connectivity, total cost of ownership PLUS sub-second search results through even the largest data volumes. Sponsored By: OCT Clinical Find out why more than 400 clinical trials annually are initiated in Russia by US and EU pharma in the free annual report by OCT Clinical. Sponsored by: PulsePoint Access this guide for the latest insights into how marketers can use data, technology, and personalized messaging to build vaccine confidence and drive successful immunization efforts. Sponsored By: Within3 We enable virtual work — offering over-time sessions where participants are more focused, insights are more diverse and business goals are met. Sponsored By: Oracle Health Sciences New research indicates an accelerated adoption of decentralized clinical trials due to COVID-19. Sponsored by: TAC Roche has inked a $1.8 billion, all-cash deal for GenMark Diagnostics, to acquire its molecular tests designed to screen patient samples for multiple infections simultaneously. Sponsored By: Almac Clinical Technologies This industry report reveals qualitative and quantitative candid insight from clinical development insiders and their views on current clinical trial challenges faced amidst uncertainty. Sponsored By: Remarque Systems Remarque Systems consolidates data, then layers on visualization and automated metrics to generate consistent, actionable data insights in real-time. Click here for more info. Sponsored By: Culture Biosciences Find out how upstream bioprocess scientists can use Culture Biosciences’ bioreactor system and real-time data visualizations to get faster insights and get their product to market more quickly. Sponsored By: BC Platforms Those wishing to unlock RWD’s true value must have access to a variety of data sources/types and the technological capabilities to use the data to uncover meaningful insights. Sponsored By: Oracle Health Sciences New research indicates an accelerated adoption of decentralized clinical trials due to COVID-19. Sponsored by: Catalent Autologous cell therapies have seen propelled growth since 2017, with the spotlight on the first FDA approval of a chimeric antigen receptor (CAR) T cell immunotherapy, Kymriah® (tisagenlecleucel), for the treatment of relapsed/refractory B-cell acute lymphoblastic leukemia. Sponsored by: Catalent Learn about drug product process development challenges and risks, the difference between innovator and biosimilar drug product process development, and more during the drug product process development phase. Sponsored by: Catalent Get insights on key considerations for a successful tech transfer process for manufacturing a biologic drug product, including a case study on overcoming challenges in a process transfer for a sterile diluent. Sponsored by: Catalent In a BioPharma Dive industry survey, planning and forecasting were identified as top concerns for trial sponsors. In response to this need, the CSM team at Catalent has developed a methodology for identifying, evaluating, and proactively managing the inherent risks involved in clinical trial supply chain management. Sponsored by: Catalent Learn how to drive excellence within the forecasting process and utilize forecasting throughout the clinical study to better plan clinical supply budgets and project timelines. Explore how to identify potential supply-related issues before they can negatively impact your study. | 
